Roivant Sciences, Cigna Ventures and Johnson & Johnson Innovation – JJDC helped push the healthcare data exchange’s overall funding to $83m.
Author: Callum Cyrus
Ninjacart puts away $30m
Corporates Walmart and Flipkart have renewed their commitment to the fresh produce distribution marketplace after initially striking up a strategic collaboration late last year.
Corporates light up Illusive’s $24m series B1
Cisco, Microsoft and Citi all returned to lift cybersecurity technology provider Illusive Networks’ total funding to $54m.
BukuWarung wraps up new funding
The merchant payment and bookkeeping app developer won investment from GMO Venture Partners in its third round this year.
Oxford Nanopore locks in $108m
The Amgen and Illumina-backed genetic sequencing equipment provider brought its funding this year to more than $206m and its overall total to about $800m.
PeelPioneers picks up fresh funding
Fruit peel recycler PeelPioneers lured Rabobank to an $11.8m round expected to facilitate the pan-European expansion of its manufacturing base.
TigerConnect crafts $45m series D message
Relx and Telus-backed TigerConnect has now raised $149m in equity and debt financing for its healthcare messaging and collaboration platform.
Evrythng tracks down $10m
You & Mr Jones put up a share of the funding as the consumer data technology provider took its overall funding to $60m.
A2 coordinates series B round
Oncology therapy developer A2 Biotherapeutics raised $71.5m from investors including Hartford HealthCare Endowment to take its funding to $136m altogether.
Onapsis zones into $55m series D
Schlumberger-backed enterprise security software provider Onapsis has now raised more than $113m altogether.
Lumos loops in more funding
Blood test provider Lumos Diagnostics secured $17.9m and aims to go public in a 2021 IPO that would provide an exit for series A lead investor Planet Innovation.
AccessFintech sets down $20m series B
JPMorgan Chase, Citi, Goldman Sachs and Deutsche Bank all reinvested in AccessFintech, creator of a financial data exchange.
Carmot curates $47m series C round
Amgen has invested in Carmot Therapeutics having previously licensed a cancer drug candidate from the company that is currently in phase 2 clinical trials.
Papaya pins down $40m series B
The Israeli investment arm of Access Industries joined Workday Ventures to help bring the human resources software provider’s overall funding to $89.5m.